Trending...
- Juneau: CBJ reports six new COVID-19 cases
- CEO of Industrial Giant ABB in Brazil Joins CEO Coaching International
- expEDIum Direct Pay®, seamless online payment added to iTech's expEDIum Medical Billing®
Juneau residents who test positive for COVID-19 and are at high risk for progressing to severe COVID-19 may be eligible for monoclonal antibody treatment.
In November 2020, the FDA issued an emergency use authorization for the use of antibodies to treat certain cases of SARS-CoV2, the virus that causes COVID-19. This includes patients 65 years of age or older or who have certain chronic medical conditions.
Eligibility for antibody therapy includes:
Please note, individuals over 65 years of age will be prioritized. Generally, a patient is not a candidate for therapy once they have been hospitalized.
More on AkGlobe News
Antibody therapy is beneficial only in patients who have been newly infected. Once the body begins producing its own antibodies, antibody therapy loses efficacy. Antibody therapy, if delivered early, has been shown to decrease hospitalizations.
If you or someone you know receives a positive COVID-19 test, contact your primary care provider immediately to evaluate the possibility of receiving monoclonal anti body treatment. If appropriate, your primary care provider will coordinate treatment with Bartlett Regional Hospital.
To learn more about monoclonal antibody therapy, please contact your primary healthcare provider.
If you do not have a primary care provider, please call the Bartlett Regional Hospital Emergency Department at 907-796-8427.
For questions, contact Bartlett Regional Hospital Community Relations Director Katie Bausler at kbausler3@bartletthospital.org or 907-796-8567.
In November 2020, the FDA issued an emergency use authorization for the use of antibodies to treat certain cases of SARS-CoV2, the virus that causes COVID-19. This includes patients 65 years of age or older or who have certain chronic medical conditions.
Eligibility for antibody therapy includes:
- Those over 65 years of age with cardiovascular disease, hypertension, chronic obstructive pulmonary disease, or chronic respiratory disease
- Those with specific, rare, preexisting conditions
- Those with mild or moderate coronavirus disease
- Those at high risk for progressing to severe COVID-19 and/or hospitalization
Please note, individuals over 65 years of age will be prioritized. Generally, a patient is not a candidate for therapy once they have been hospitalized.
More on AkGlobe News
- Alaska: Governor Dunleavy Recognizes Right to Life Day
- Alaska: Right to Life Day
- Kaizen Finance Launches Staking to Foster the Widespread Adoption of DeFi
- Ismail Sirdah Describes the Best Practices for Holding Corporate Events
- MDAdvantage Appoints Pete Cammarano to Board of Directors
Antibody therapy is beneficial only in patients who have been newly infected. Once the body begins producing its own antibodies, antibody therapy loses efficacy. Antibody therapy, if delivered early, has been shown to decrease hospitalizations.
If you or someone you know receives a positive COVID-19 test, contact your primary care provider immediately to evaluate the possibility of receiving monoclonal anti body treatment. If appropriate, your primary care provider will coordinate treatment with Bartlett Regional Hospital.
To learn more about monoclonal antibody therapy, please contact your primary healthcare provider.
If you do not have a primary care provider, please call the Bartlett Regional Hospital Emergency Department at 907-796-8427.
For questions, contact Bartlett Regional Hospital Community Relations Director Katie Bausler at kbausler3@bartletthospital.org or 907-796-8567.
0 Comments
Latest on AkGlobe News
- Love & Sip Valentine Brunch with Celebrity The Comedian, Tomea, Grammy Saxophonist Jason Davis, Gospel Contemporary Duo, Only God Ministries
- Rustic Deco Launches B2B Wholesale Furniture Website
- IOTech names Gavin Hunter as VP of global marketing
- Introducing BIAMI.IO Apps Framework
- Juneau: CBJ reports six new COVID-19 cases
- Alaska: Governor Dunleavy Issues Statement on Biden's Halt of ANWR Development
- Juneau's 14-day COVID-19 recap: Jan. 4 – Jan. 17
- City Streaming TV, a Streaming Television Inc Network Launches, bringing Community and Faith Leaders into local TV's, At No Cost
- BoatDealers.ca Surges with Record Traffic in 2020
- 'Aesthetic Institute of Massachusetts' Announces Rebranding to 'Aesthetic Mentor'
- OCC Adopts Final Rule Requiring Large Banks to Provide Fair Access to Banking Services
- The Antenna Company Announces Venture Debt Financing Agreement with Brabant Development Agency (BOM)
- CBJ reports 22 new COVID-19 cases in Juneau Jan. 16-19
- Code18 Interactive Launches New Websites for Balmex and Balmex Adult
- List of Juneau vaccine providers enrolled with the State of Alaska
- The Atlas Group adds Corbin Raines to their list of professional property managers
- Latino Leaders Network to Honor Tucson Mayor Regina Romero with the Antonio Villaraigosa Leadership Award at the 34th Tribute to Mayors
- The UK's Leading Digital Marketing Agency, Finsbury Media Announces Employees Will Be Allowed To Work From Home:
- NMEA 2000 Development and Prototyping Boards for Marine Applications
- ICTBroadast Version 4.1, Advance call center software for your needs